United States · FDA National Drug Code directory

Amikacin Sulfate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
23155-785_7f946330-e4c6-4643-903d-3695d08df7d6
Product NDC
23155-785
Form
INJECTION, SOLUTION
Composition / generic term
Amikacin Sulfate
Labeler
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20201215
Source listing expiry
20261231

Source-listed ingredients

  • AMIKACIN SULFATE — 500 mg/2mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 VIAL, GLASS in 1 CARTON (23155-785-41) / 2 mL in 1 VIAL, GLASS (23155-785-31) · 23155-785-41

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →